The analysis of a cohort of consecutive non-selected patients from the Strasbourg University Hospital, and therefore representative of the real life, will allow better identifying the risk factors for these infections (by comparison with a cohort of patient with similar conditions of immunosuppression and no infection) and improving the diagnosis and therapeutic management. The primary objective is to identify prognosis factors affecting survival in patients with opportunistic infections
Study Type
OBSERVATIONAL
Enrollment
1,000
University Hospital, Strasbourg, france
Strasbourg, France
RECRUITINGShort- and long-term survival, overall and in specific subgroups of patients
Time frame: Long-term time point : 1st may 2019
Short- and long-term survival, overall and in specific subgroups of patients
Time frame: Short term : 1 month
Short- and long-term survival, overall and in specific subgroups of patients
Time frame: Short term : 3 months
Short- and long-term survival, overall and in specific subgroups of patients
Time frame: Short term : 6 months
Risk factors predisposing to opportunistic infections - age - gender - Type of work - Location - Tobacco use
Time frame: first day of opportunistic infection
Prognosis factors in patients with opportunistic infection affecting the response to antimicrobial therapy (using response criteria defined by EORTC/MSG)
Time frame: first day of opportunistic infection
Identification of baseline prognosis factors affecting the 3 months survival
Time frame: first day of opportunistic infection
Identification of baseline prognosis factors affecting the 6 months survival
Time frame: first day of opportunistic infection
Incidence of specific opportunistic infections in different host groups
Time frame: evolution of a 20-year-period
Description of imaging patterns opportunistic infections: analysis of chest CT-scan and cerebral CT-scan and MRI by radiologists
Time frame: at first day of infection and up to 12 weeks
Assessment of performance of Aspergillus galactomannan detection test in serum
Time frame: at onset and up to 1 week
Assessment of performance of Aspergillus galactomannan detection test in bronchoalveolar lavage
Time frame: at onset and up to 1 week
Response rate
Time frame: at 1, 3 and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.